Cross Country Healthcare, Inc. (NASDAQ:CCRN) VP Cynthia Ann Grieco Sells 1,945 Shares

Cross Country Healthcare, Inc. (NASDAQ:CCRN) VP Cynthia Ann Grieco sold 1,945 shares of Cross Country Healthcare stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $17.21, for a total value of $33,473.45. Following the transaction, the vice president now owns 7,605 shares of the company’s stock, valued at approximately $130,882.05. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Cross Country Healthcare Stock Performance

Shares of NASDAQ:CCRN traded down $0.55 during trading on Monday, hitting $16.56. The company’s stock had a trading volume of 440,190 shares, compared to its average volume of 432,594. The business has a 50 day moving average price of $14.76 and a two-hundred day moving average price of $16.97. The company has a market capitalization of $575.86 million, a PE ratio of 12.74, a P/E/G ratio of 2.57 and a beta of 0.63. Cross Country Healthcare, Inc. has a fifty-two week low of $12.87 and a fifty-two week high of $26.17.

Cross Country Healthcare (NASDAQ:CCRN) last posted its quarterly earnings results on Wednesday, July 31st. The business services provider reported $0.10 EPS for the quarter, missing the consensus estimate of $0.14 by ($0.04). The business had revenue of $339.77 million during the quarter, compared to analyst estimates of $334.75 million. Cross Country Healthcare had a return on equity of 7.29% and a net margin of 0.54%. The business’s revenue was down 37.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.69 EPS. As a group, equities analysts expect that Cross Country Healthcare, Inc. will post 0.68 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Cross Country Healthcare

Several institutional investors have recently modified their holdings of CCRN. Gladius Capital Management LP lifted its position in Cross Country Healthcare by 37.1% in the fourth quarter. Gladius Capital Management LP now owns 1,902 shares of the business services provider’s stock valued at $43,000 after acquiring an additional 515 shares during the last quarter. SummerHaven Investment Management LLC raised its holdings in shares of Cross Country Healthcare by 2.0% in the fourth quarter. SummerHaven Investment Management LLC now owns 26,927 shares of the business services provider’s stock valued at $610,000 after buying an additional 520 shares during the last quarter. Raymond James & Associates raised its holdings in shares of Cross Country Healthcare by 0.7% in the second quarter. Raymond James & Associates now owns 165,324 shares of the business services provider’s stock valued at $2,288,000 after buying an additional 1,155 shares during the last quarter. GAMMA Investing LLC purchased a new stake in shares of Cross Country Healthcare in the fourth quarter valued at about $28,000. Finally, Price T Rowe Associates Inc. MD raised its holdings in shares of Cross Country Healthcare by 9.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 16,639 shares of the business services provider’s stock valued at $312,000 after buying an additional 1,450 shares during the last quarter. Institutional investors and hedge funds own 96.03% of the company’s stock.

Analysts Set New Price Targets

CCRN has been the topic of a number of analyst reports. Barrington Research dropped their target price on Cross Country Healthcare from $24.00 to $21.00 and set an “outperform” rating on the stock in a research report on Monday, May 6th. Truist Financial raised their target price on shares of Cross Country Healthcare from $16.00 to $17.00 and gave the stock a “hold” rating in a research note on Thursday. Finally, Benchmark reduced their price target on shares of Cross Country Healthcare from $21.00 to $19.00 and set a “buy” rating on the stock in a research report on Thursday, May 2nd. Six equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, Cross Country Healthcare presently has a consensus rating of “Hold” and an average price target of $21.00.

About Cross Country Healthcare

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.